background


Product Information:

SNDX-5613

SNDX-5613 (Revumenib) is a potent and selective inhibitor of menin-MLL binding with a Ki of 0.15 nM. SNDX-5613 shows anti-proliferative activity.

Cat. No.: EX-A4343    Purity: >98%
SNDX-5613
For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
100mg750In-stock
200mg1150In-stock
500mg1750In-stock
1g2550In-stock
5g6850In-stock
10g9950In-stock


SynonymsRevumenib
CAS No.2169919-21-3
Purity>98%
FormulaC32H47FN6O4S
Mol Weight630.817
Appearancesolid powder
SolubilitySoluble in DMSO
Shelf Life>2 years if stored properly
StoragePowder -20℃ 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  [1]. A drug, SNDX-5613, to treat acute leukemia with a KMT2A translocation or an NPM1 mutation that has come back (relapsed) or has not gotten better with treatment (refractory).
CoACoA of SNDX-5613

KEYWORDS: buy SNDX-5613 | SNDX-5613 supplier | purchase | cost | manufacturer | order | distributor | buy 2169919-21-3 | 2169919-21-3 supplier